07:50 AM EDT, 07/25/2024 (MT Newswires) -- AbbVie ( ABBV ) reported Q2 adjusted earnings Thursday of $2.65 per diluted share, down from $2.91 a year earlier.

Analyst polled by Capital IQ expected $2.66.

Net revenue for the quarter ended June 30 was $14.46 billion, up from $13.87 billion a year earlier.

Analyst polled by Capital IQ expected $14.03 billion.

The company now expects full year 2024 adjusted diluted EPS of $10.71 to $10.91, raising its previous guidance of $10.61 to $10.81. Analysts surveyed by Capital IQ are expecting $10.90.

Price: 178.60, Change: +2.39, Percent Change: +1.36